Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,187 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for
IC-MPGN
Location: Cincinnati OH, London, St Louis MO, Madison WI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 60

Code: NCT05755386

Phase 3, Recruiting

Critical Health Assessment and Outcomes Score/Study

for
Critical Illness, Death, Sudden
Location: Cincinnati OH
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT02766166

Recruiting

Caregiver Wellness After Traumatic Brain Injury (CG-WELL): An Intervention Designed to Promote Well-being in Caregivers of Acute Moderate to Severe Traumatic Brain Injuries

for
Trauma, Brain
Location: Cincinnati OH
Sponsor: Natalie Kreitzer

Sex: All

Age: 18+

Code: NCT05307640

Recruiting

B-Cell Targeted Carfilzomib Desensitization

for
Transplants and Implants
Location: Cincinnati OH
Sponsor: E. Steve Woodle

Sex: All

Age: 18 - 65

Code: NCT02442648

Phase 1, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Cincinnati OH, Lexington KY, Jeffersonville IN,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: Cincinnati OH, Louisville KY, Pittsburgh PA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase 1, Phase 2, Recruiting

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH, Columbus OH, Goshen IN, Dallas TX
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase 1, Phase 2, Recruiting

Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules

for
Indeterminate Thyroid Cytology
Location: Cincinnati OH, Guntersville AL, New Orleans LA,
Sponsor: Pontificia Universidad Catolica de Chile

Sex: All

Age: 18+

Code: NCT03309631

Recruiting

Zopa Retreatment and Vector Shedding in Adults With RRP

for
Recurrent Respiratory Papillomatosis, Papillomavirus Infection,
Location: Cincinnati OH, Bethesda MD, Atlanta GA
Sponsor: Precigen, Inc

Sex: All

Age: 18+

Code: NCT06538480

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Cincinnati OH, Edgewood KY, Louisville KY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

for
Symptomatic Venous Thromboembolism (VTE)
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07213778

Phase 3, Recruiting

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

for
Breast Cancer, Surgery
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18 - 70

Code: NCT07528638

Recruiting

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

for
Cervical Cancer, Radiation Therapy Complication,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: Female

Age: 18+

Code: NCT07447895

Recruiting

A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

for
Traumatic Brain Injury
Location: Cincinnati OH, Pittsburgh PA, Charlotte NC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07455136

Recruiting

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

for
Cystic Fibrosis
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18 - 45

Code: NCT06163482

Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

for
Primary Progressive Multiple Sclerosis,
Location: Cincinnati OH, St Louis MO, Durham NC, Rochester MN,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT07477639

Phase 1, Phase 2, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Cincinnati OH, Columbus OH, Louisville KY, Detroit MI,
Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase 2, Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

for
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
Location: Cincinnati OH, Columbus OH, Maumee OH, St Louis MO,
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07154823

Recruiting

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Cincinnati OH, Chicago IL, London, Charlottesville VA,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07094087

Phase 3, Recruiting

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

for
CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT07108998

Phase 2, Recruiting